Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Kiran Multi Super Speciality Hospital

Verified

Basic Information

Site Overview

Source: Human-provided.

Kiran Hospital, a multi-super-speciality hospital and research centre in Surat, Gujarat, also engages in clinical research activities as part of its broader healthcare mission. Through its clinical research function, the hospital supports studies involving people, health data, and biological samples to better understand disease processes and improve prevention, diagnosis, and treatment methods. This encompasses observational studies and different phases of clinical trials that contribute to developing new and improved medical interventions and treatments. By integrating research with clinical services, Kiran Hospital aims to advance medical knowledge and enhance patient outcomes while maintaining high standards of care.

Source: Trial-derived.
12Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
25Unique Conditions
Source: Trial-derived.
8Unique Sponsors

Affiliations

Associated Organizations

Conditions

Source: Trial-derived. Acute Myeloid Leukemia (1)Source: Trial-derived. Acute Myocardial Infarction (1)Source: Trial-derived. Advanced Malignant Neoplasm (1)Source: Trial-derived. Colon Cancer (1)Source: Trial-derived. Colorectal Cancer (1)Source: Trial-derived. Esophagus Cancer (1)Source: Trial-derived. Gastric Cancer (1)Source: Trial-derived. Gastroesophageal Junction Adenocarcinoma (1)

Sponsors

Source: Trial-derived. Aurigene Discovery Technologies Limited (7)Source: Trial-derived. Bristol Myers Squibb Company (BMS) (1)Source: Trial-derived. Indian Society of Critical Care Medicine (1)Source: Trial-derived. Janssen Research & Development, LLC (1)Source: Trial-derived. Lupin Ltd. (1)Source: Trial-derived. OnQuality Pharmaceuticals (USA) LLC (1)Source: Trial-derived. Tata Memorial Centre (1)Source: Trial-derived. Viatris Innovation GmbH (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Dedicated Phase 1 Unit

Source: Human-provided. Yes

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 30

Principal investigators

Source: Human-provided. 10

Study coordinators

Source: Human-provided. 20

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Amenities

Amenities Available

Source: Google. Gender-neutral restroom
Source: Google. Nursing room

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Autoinjector self-administration training